These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 26997309)

  • 1. Systemic Nonurological Symptoms in Patients with Overactive Bladder.
    Lai HH; Vetter J; Jain S; Andriole GL
    J Urol; 2016 Aug; 196(2):467-72. PubMed ID: 26997309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sleep Disturbance and Fatigue Are Associated With More Severe Urinary Incontinence and Overactive Bladder Symptoms.
    Ge TJ; Vetter J; Lai HH
    Urology; 2017 Nov; 109():67-73. PubMed ID: 28826875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Relationship Between Anxiety and Overactive Bladder or Urinary Incontinence Symptoms in the Clinical Population.
    Lai HH; Rawal A; Shen B; Vetter J
    Urology; 2016 Dec; 98():50-57. PubMed ID: 27450939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between psychological stress levels and the severity of overactive bladder symptoms.
    Lai H; Gardner V; Vetter J; Andriole GL
    BMC Urol; 2015 Mar; 15():14. PubMed ID: 25887525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of childhood and recent traumatic events on the clinical presentation of overactive bladder.
    Lai HH; Morgan CD; Vetter J; Andriole GL
    Neurourol Urodyn; 2016 Nov; 35(8):1017-1023. PubMed ID: 26332868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between depression and overactive bladder/urinary incontinence symptoms in the clinical OAB population.
    Lai HH; Shen B; Rawal A; Vetter J
    BMC Urol; 2016 Oct; 16(1):60. PubMed ID: 27716241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clustering of patients with overactive bladder syndrome.
    Gross J; Vetter JM; Lai HH
    BMC Urol; 2021 Mar; 21(1):41. PubMed ID: 33740925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of urinary incontinence on healthcare resource utilization, health-related quality of life and productivity in patients with overactive bladder.
    Tang DH; Colayco DC; Khalaf KM; Piercy J; Patel V; Globe D; Ginsberg D
    BJU Int; 2014 Mar; 113(3):484-91. PubMed ID: 24528881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The validation of the Dutch OAB-q SF: An overactive bladder symptom bother and health-related quality of life short-form questionnaire.
    Groenendijk IM; Scheepe JR; Noordhoff TC; Blok BFM
    Neurourol Urodyn; 2019 Aug; 38(6):1775-1782. PubMed ID: 31215693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life and the prevalence of urinary incontinence after surgical treatment for gynecologic cancer: a questionnaire survey.
    Nakayama N; Tsuji T; Aoyama M; Fujino T; Liu M
    BMC Womens Health; 2020 Jul; 20(1):148. PubMed ID: 32680500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study.
    Coyne KS; Sexton CC; Irwin DE; Kopp ZS; Kelleher CJ; Milsom I
    BJU Int; 2008 Jun; 101(11):1388-95. PubMed ID: 18454794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial.
    Chapple C; Sievert KD; MacDiarmid S; Khullar V; Radziszewski P; Nardo C; Thompson C; Zhou J; Haag-Molkenteller C
    Eur Urol; 2013 Aug; 64(2):249-56. PubMed ID: 23608668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linguistic validation of the N-QOL (ICIQ), OAB-q (ICIQ), PPBC, OAB-S and ICIQ-MLUTSsex questionnaires in 16 languages.
    McKown S; Abraham L; Coyne K; Gawlicki M; Piault E; Vats V
    Int J Clin Pract; 2010 Nov; 64(12):1643-52. PubMed ID: 20722767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of overactive bladder on quality of life and resource use: results from Korean Burden of Incontinence Study (KOBIS).
    Lee KS; Choo MS; Seo JT; Oh SJ; Kim HG; Ng K; Lee KJ; Tan JT; Kim JC
    Health Qual Life Outcomes; 2015 Jun; 13():89. PubMed ID: 26113125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of tolterodine ER on patient-reported outcomes in sexually active women with overactive bladder and urgency urinary incontinence.
    Rogers RG; Bachmann G; Scarpero H; Jumadilova Z; Sun F; Morrow JD; Guan Z; Bavendam T
    Curr Med Res Opin; 2009 Sep; 25(9):2159-65. PubMed ID: 19601704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary incontinence, overactive bladder, and quality of life in women submitted to total hip replacement.
    Martines GA; Tamanini JTN; Mota GMDS; Barreto ET; Santos JLF; Sartori MGF; Girão MJBC; Castro RA
    Neurourol Urodyn; 2022 Mar; 41(3):830-840. PubMed ID: 35114028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does the Severity of Overactive Bladder Symptoms Correlate With Risk for Female Sexual Dysfunction?
    Juliato CRT; Melotti IGR; Junior LCS; Britto LGO; Riccetto CLZ
    J Sex Med; 2017 Jul; 14(7):904-909. PubMed ID: 28622875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of overactive bladder and nocturia as a risk factor for hip fracture in climacteric women: a matched pair case control study.
    Karabulut A; Simavlı S; Demirtaş Ö; Ök N; Güngör HR; Zümrütbaş A
    J Obstet Gynaecol; 2018 Feb; 38(2):252-256. PubMed ID: 28903631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overactive bladder and its effects on sexual dysfunction among women.
    Ergenoglu AM; Yeniel AÖ; Itil IM; Askar N; Meseri R; Petri E
    Acta Obstet Gynecol Scand; 2013 Oct; 92(10):1202-7. PubMed ID: 23782424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overactive bladder and associated psychological symptoms: A possible link to vitamin D and calcium.
    Abdul-Razzak KK; Alshogran OY; Altawalbeh SM; Al-Ghalayini IF; Al-Ghazo MA; Alazab RS; Halalsheh OM; Sahawneh FE
    Neurourol Urodyn; 2019 Apr; 38(4):1160-1167. PubMed ID: 30869826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.